149 related articles for article (PubMed ID: 28807470)
1. Persistent Pulmonary Embolism Rates Following Total Knee Arthroplasty Even With Prophylactic Anticoagulants.
Cote MP; Chen A; Jiang Y; Cheng V; Lieberman JR
J Arthroplasty; 2017 Dec; 32(12):3833-3839. PubMed ID: 28807470
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary Embolism Rates Following Total Hip Arthroplasty With Prophylactic Anticoagulation: Some Pulmonary Emboli Cannot Be Avoided.
Lieberman JR; Cheng V; Cote MP
J Arthroplasty; 2017 Mar; 32(3):980-986. PubMed ID: 27866948
[TBL] [Abstract][Full Text] [Related]
3. Symptomatic in-hospital deep vein thrombosis and pulmonary embolism following hip and knee arthroplasty among patients receiving recommended prophylaxis: a systematic review.
Januel JM; Chen G; Ruffieux C; Quan H; Douketis JD; Crowther MA; Colin C; Ghali WA; Burnand B;
JAMA; 2012 Jan; 307(3):294-303. PubMed ID: 22253396
[TBL] [Abstract][Full Text] [Related]
4. A Phase IV Study of Thromboembolic and Bleeding Events Following Hip and Knee Arthroplasty Using Oral Factor Xa Inhibitor.
Gomez D; Razmjou H; Donovan A; Bansal VB; Gollish JD; Murnaghan JJ
J Arthroplasty; 2017 Mar; 32(3):958-964. PubMed ID: 27843040
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness and safety of rivaroxaban for the prevention of thrombosis following total hip or knee replacement: A systematic review and meta-analysis.
Liu J; Zhao J; Yan Y; Su J
Medicine (Baltimore); 2019 Mar; 98(9):e14539. PubMed ID: 30817570
[TBL] [Abstract][Full Text] [Related]
6. Continuous passive motion for preventing venous thromboembolism after total knee arthroplasty.
He ML; Xiao ZM; Lei M; Li TS; Wu H; Liao J
Cochrane Database Syst Rev; 2014 Jul; 2014(7):CD008207. PubMed ID: 25069620
[TBL] [Abstract][Full Text] [Related]
7. Continuous passive motion for preventing venous thromboembolism after total knee arthroplasty.
He ML; Xiao ZM; Lei M; Li TS; Wu H; Liao J
Cochrane Database Syst Rev; 2012 Jan; 1():CD008207. PubMed ID: 22258981
[TBL] [Abstract][Full Text] [Related]
8. The Role of Intraoperative Intermittent Pneumatic Compression Devices in Venous Thromboembolism Prophylaxis in Total Hip and Total Knee Arthroplasty.
Tyagi V; Tomaszewski P; Lukasiewicz A; Theriault S; Pelker R
Orthopedics; 2018 Jan; 41(1):e98-e103. PubMed ID: 29156069
[TBL] [Abstract][Full Text] [Related]
9. Low-Dose Aspirin Is Safe and Effective for Venous Thromboembolism Prophylaxis Following Total Knee Arthroplasty.
Faour M; Piuzzi NS; Brigati DP; Klika AK; Mont MA; Barsoum WK; Higuera CA
J Arthroplasty; 2018 Jul; 33(7S):S131-S135. PubMed ID: 29656974
[TBL] [Abstract][Full Text] [Related]
10. Analysis of contributing factors influencing thromboembolic events after total knee arthroplasty.
Plante S; Belzile EL; Fréchette D; Lefebvre J
Can J Surg; 2017 Feb; 60(1):30-36. PubMed ID: 28234587
[TBL] [Abstract][Full Text] [Related]
11. Rate of Transfusions After Total Knee Arthroplasty in Patients Receiving Lovenox or High-Dose Aspirin.
Radzak KN; Wages JJ; Hall KE; Nakasone CK
J Arthroplasty; 2016 Nov; 31(11):2447-2451. PubMed ID: 27554782
[TBL] [Abstract][Full Text] [Related]
12. Are bilateral total joint arthroplasty patients at a higher risk of developing pulmonary embolism following total hip and knee surgery?
Yeager AM; Ruel AV; Westrich GH
J Arthroplasty; 2014 May; 29(5):900-2. PubMed ID: 24360492
[TBL] [Abstract][Full Text] [Related]
13. Direct factor Xa inhibitors (rivaroxaban and apixaban) versus enoxaparin for the prevention of venous thromboembolism after total knee replacement: A meta-analysis of 6 randomized clinical trials.
Ma G; Zhang R; Wu X; Wang D; Ying K
Thromb Res; 2015 May; 135(5):816-22. PubMed ID: 25728496
[TBL] [Abstract][Full Text] [Related]
14. Incidence and Fate of "Symptomatic" Venous Thromboembolism After Knee Arthroplasty Without Pharmacologic Prophylaxis in an Asian Population.
Park YG; Ha CW; Lee SS; Shaikh AA; Park YB
J Arthroplasty; 2016 May; 31(5):1072-7. PubMed ID: 26777576
[TBL] [Abstract][Full Text] [Related]
15. Development and Validation of a Risk Stratification System for Pulmonary Embolism After Elective Primary Total Joint Arthroplasty.
Bohl DD; Maltenfort MG; Huang R; Parvizi J; Lieberman JR; Della Valle CJ
J Arthroplasty; 2016 Sep; 31(9 Suppl):187-91. PubMed ID: 27067463
[TBL] [Abstract][Full Text] [Related]
16. Rivaroxaban for thromboprophylaxis after total hip or knee arthroplasty: a meta-analysis with trial sequential analysis of randomized controlled trials.
Ning GZ; Kan SL; Chen LX; Shangguan L; Feng SQ; Zhou Y
Sci Rep; 2016 Mar; 6():23726. PubMed ID: 27020475
[TBL] [Abstract][Full Text] [Related]
17. Clinical Performance of the 1st American Academy of Orthopaedic Surgeons Clinical Guideline on Prevention of Symptomatic Pulmonary Embolism after Total Knee Arthroplasty in Korean Patients.
Na YG; Fang R; Kim YH; Cho KJ; Kim TK
J Korean Med Sci; 2015 Dec; 30(12):1865-73. PubMed ID: 26713064
[TBL] [Abstract][Full Text] [Related]
18. A prospective comparison of warfarin to aspirin for thromboprophylaxis in total hip and total knee arthroplasty.
Intermountain Joint Replacement Center Writing Committee
J Arthroplasty; 2012 Jan; 27(1):1-9.e2. PubMed ID: 21621959
[TBL] [Abstract][Full Text] [Related]
19. Prediction of Venous Thromboembolism after Total Knee Arthroplasty Using Dielectric Blood Coagulometry.
Uchiyama H; Inoue Y; Uchimura I; Nakamura T; Kudo T; Muneta T; Kawano T
Ann Vasc Surg; 2017 Jan; 38():286-292. PubMed ID: 27522973
[TBL] [Abstract][Full Text] [Related]
20. The Role of Aspirin and Unfractionated Heparin Combination Therapy Immediately After Total Hip and Knee Arthroplasty.
Sobh AH; Koueiter DM; Mells A; Siljander MP; Karadsheh MS
Orthopedics; 2018 May; 41(3):171-176. PubMed ID: 29570760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
